Glucosil™

Antimicrobial Resistance Fighting Technology

Glucosil silver chitosan attacks on bacterial cells include electrostatic disruption, membrane damage, biofilm inhibition, and oxidative/metal ion stress. These diverse targets make it much harder for bacteria to evolve effective resistance. With a multi-stage multi-modal process bacterial RNA has not been able to synthesize enzymes that form new resistant proteins. Research conducted at the Australian Institute of Microbiology and Infection at the University of Technology Sydney, validates the efficacy of Glucosil to kill multi-drug resistant pathogens while minimizing the tendency of bacteria to develop resistance.

• Glucosil penetrates existing biofilm and eradicates them by killing the biofilm forming bacterial threat.

• Glucosil inhibits formation of new biofilms.

• Glucosil kills infectious disease causing bacteria and fungal threats and inactivates viruses listed on the CDC and World health Organization as “Critical Threats”.

• Glucosil has passed safety and toxicity studies as a minimal risk and its safety in human and animal use is supported by numerous scientific studies.